<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Extrahepatic portal venous system <z:mp ids='MP_0005048'>thrombosis</z:mp> (EPVST) occurs in 13% of patients with either recurrent <z:hpo ids='HP_0011009'>acute</z:hpo> (AP) or <z:hpo ids='HP_0011010'>chronic</z:hpo> (CP) alcoholic <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The role of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> has never been assessed in this entity </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> consecutive patients with alcoholic AP or CP were included in a prospective study </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent a computerized tomography (CT) scan of the pancreas to evaluate EPVST as well as thorough testing for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (protein C, S, and <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e>, factor II, factor V, and JAK2 gene mutations, homocystein, biological <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 119 patients (male, n=100 (84%); smokers, n=110 (92%)) were included </plain></SENT>
<SENT sid="5" pm="."><plain>EPVST was found in 41 patients (35%) </plain></SENT>
<SENT sid="6" pm="."><plain>The portal, superior mesenteric, or splenic veins were involved in 34%, 24%, and 93% of patients, respectively </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> was identified in 18% (n=22), including the biological <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, and factor II G20210A gene mutation in 21 (17.6%), 2 (1.6%), and 1 patient (0.8%), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>On univariate analysis, the factors associated with EPVST were smoking (RR=1.6 (1.38-1.85), P=0.03), <z:mpath ids='MPATH_468'>pseudocysts</z:mpath> (RR=2.91 (1.29-6.56), P=0.008), a <z:mpath ids='MPATH_468'>pseudocyst</z:mpath> in the pancreatic tail (P=0.03), a high CT severity index for AP (P=0.007), and pancreatic parenchymal <z:mp ids='MP_0001651'>necrosis</z:mp> (P=0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>The presence of hemostatic risk factors was not associated with an increased risk of EPVST </plain></SENT>
<SENT sid="10" pm="."><plain>On multivariate analysis, only <z:mpath ids='MPATH_468'>pseudocysts</z:mpath> were associated with EPVST (hazard ratio: 6.402; 95% confidence interval (1.59-26.54), P=0.009) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: EPVST is found in 35% of patients with <z:hpo ids='HP_0011009'>acute</z:hpo>/<z:hpo ids='HP_0011010'>chronic</z:hpo> alcoholic <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Local <z:mp ids='MP_0001845'>inflammation</z:mp> appears to be the major predisposing condition </plain></SENT>
<SENT sid="13" pm="."><plain>The presence of some form of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> does not increase the risk of EPVST and should not be systematically searched for in case of EPVST </plain></SENT>
</text></document>